Pharming (PHAR) Inventory (2018 - 2026)

Pharming (PHAR) has 9 years of Inventory data on file, last reported at $65.4 million in Q2 2026.

• Quarterly Inventory rose 2.69% year-over-year to $65.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $65.4 million (up 2.69% YoY) and the FY2025 annual result came in at $64.9 million, up 16.47% from the prior year.
• Inventory improved to $65.4 million in Q2 2026, from $64.6 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $67.1 million in Q3 2025 to a low of -$4.3 million in Q4 2023.
• A 5-year average of $46.1 million and a median of $55.8 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2022 — Inventory sank 7250.34% — and 2023, when it jumped 159390.84%.
• Tracing PHAR's Inventory over 5 years: stood at -$2.0 million in 2022, then tumbled by 116.95% to -$4.3 million in 2023, then soared by 1403.18% to $55.7 million in 2024, then increased by 16.47% to $64.9 million in 2025, then grew by 0.81% to $65.4 million in 2026.
• The last three Inventory figures came in at $65.4 million (Q2 2026), $64.6 million (Q1 2026), and $64.9 million (Q4 2025), per Business Quant data.